Showing results (91-100 of 1,748) with videos related to

Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 6, 2012
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignanciesCarlos A Ramos, Neeharika Narala, Gayatri M Vyas, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 5, 2013
Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: efficacy, safety, and activity of Ad-GM·CAIX in immunocompetent mouse modelsFrédéric D Birkhäuser, Richard C Koya, Caleb Neufeld, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 5, 2013
Sleeping beauty system to redirect T-cell specificity for human applicationsSourindra N Maiti, Helen Huls, Harjeet Singh, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 23, 2013
Antileukemic T-cell responses can be predicted by the composition of specific regulatory T-cell subpopulationsJulia Schick, Valentin Vogt, Marion Zerwes, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 23, 2013
Chemical castration of melanoma patients does not increase the frequency of tumor-specific CD4 and CD8 T cells after peptide vaccinationLuis M Vence, Chiyu Wang, Himabindu Pappu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 1, 1997
Effects of hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan on pulmonary function assessmentsS Sleijfer, R J van Ginkel, T W van der Mark, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 2, 2002
Death receptor ligands in tumorsPaola Cappello, Francesco Novelli, Guido Forni, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 2, 2002
Antitumor effects of Flt3 ligand in transplanted murine tumor modelsBruce J Averbook, Joann L Schuh, Robert Papay, et al.
Pageof 175